In vitro responses of human prostate tumour cell lines to a range of antitumour agents
Related Experiment Videos
Abstract:
Four human prostate tumour continuous cell lines were employed for in vitro drug sensitivity testing of nine cytotoxic drugs, X-irradiation and two hormonal preparations. Responses were assessed by measuring cell survival as judged by colony formation in agarose. A marked heterogeneity of responses was noted to many of the agents studied, including X-irradiation. However, in terms of ID70 values for 24-h drug exposures, comparable responses in all the cell lines tested, with values falling within a 1.4- to 2.9-fold range, were noted with actinomycin D, adriamycin, m-AMSA, dibromodulcitol, 5-fluorouracil, hydroxyurea and ICRF-159. In contrast, mixed responses to cis-platinum and methotrexate were particularly marked, with ID70 values differing by factors of 3.8 and 7.5 respectively. In addition, when higher drug concentrations of m-AMSA, cis-platinum, dibromodulcitol and ICRF-159 were employed, significant deviations in the four survival curves became apparent. Continuous exposure to diethylstilboestrol and medroxyprogesterone acetate caused negligible cell kill. Due to these variable responses it was not possible to predict that any agent tested might have specific value in the treatment of prostate cancer. However, preliminary in vitro screening with such a panel of cell lines may complement in vivo studies with models of prostatic cancer and prove useful in investigations of mechanisms of drug resistance.
Insights
Prostate cancer cell lines showed varied responses to cytotoxic drugs and X-irradiation. Some drugs like actinomycin D and adriamycin demonstrated comparable sensitivity across cell lines, aiding resistance mechanism studies.
Area of Science:
- Oncology
- Pharmacology
- Cancer Cell Biology
Background:
- Prostate cancer treatment faces challenges due to variable drug responses.
- Understanding cellular sensitivity to cytotoxic agents is crucial for effective therapy.
Purpose of the Study:
- To evaluate the in vitro sensitivity of human prostate cancer cell lines to various cytotoxic drugs, X-irradiation, and hormonal preparations.
- To identify potential agents with consistent efficacy across different cell lines.
Main Methods:
- Utilized four human prostate tumor continuous cell lines for in vitro drug sensitivity testing.
- Assessed cell survival via colony formation in agarose after exposure to nine cytotoxic drugs, X-irradiation, and two hormonal agents.
- Determined drug sensitivity using ID70 values for 24-hour exposures.
Main Results:
- Significant heterogeneity in responses was observed for most agents, including X-irradiation.
- Actinomycin D, adriamycin, m-AMSA, dibromodulcitol, 5-fluorouracil, hydroxyurea, and ICRF-159 showed comparable responses (1.4- to 2.9-fold range) across cell lines.
- Cis-platinum and methotrexate exhibited marked variations in sensitivity (3.8- and 7.5-fold differences, respectively).
- Hormonal preparations (diethylstilboestrol, medroxyprogesterone acetate) resulted in negligible cell kill.
Conclusions:
- In vitro drug sensitivity testing revealed significant variability in prostate cancer cell line responses.
- While some agents showed comparable efficacy, no single agent could be reliably predicted for specific prostate cancer treatment based on this panel.
- Preliminary in vitro screening can complement in vivo studies and aid in understanding drug resistance mechanisms in prostate cancer.